News >

Immunotherapy Combos Generate Excitement in Metastatic Nonsquamous NSCLC

Kristi Rosa
Published: Wednesday, Oct 09, 2019

Sonam Puri, MD, an assistant professor in medical oncology at Huntsman Cancer Institute, University of Utah

Sonam Puri, MD

The combination of immunotherapy and chemotherapy in the frontline treatment of metastatic nonsquamous non–small cell lung cancer (NSCLC) has been a game changer, said Sonam Puri, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
The Patient and Provider Connection™: Effective Communication to Optimize the Diagnosis and Management of Irritable Bowel Syndrome and Chronic Idiopathic ConstipationOct 31, 20191.0
Publication Bottom Border
Border Publication